Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-14

Clinical Trial Update: Tumor Budding and T1 Substaging in Urothelial Bladder Cancer

View source ↗

Summary

A clinical trial update focusing on tumor budding and T1 sub-staging in urothelial bladder cancer; recruitment is not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Assiut University | Conditions: Urothelial Bladder Carcinoma, Bladder Carcinoma | Status: NOT_YET_RECRUITING